Validation of chromatographic analytical methods, TLC and HPLC, to determine the radiochemical purity on the radiopharmaceutical [177Lu]-PSMA I&T

Carregando...
Imagem de Miniatura

Data

Data de publicação

Orientador

Título da Revista

ISSN da Revista

Título do Volume

É parte de

É parte de

É parte de

SSRN Electronic Journal
Exportar
Mendeley

Projetos de Pesquisa

Unidades Organizacionais

Fascículo

Resumo
The Energy and Nuclear Research Institute (IPEN) is studying the production of the radiopharmaceutical [177Lu]-PSMA I&T, in accordance with the good manufacturing practices recommended by ANVISA, to be used in the therapy of prostate cancer. This work aims to validate chromatographic methods, TLC and HPLC, to determine the radiochemical purity of the product. The entire validation process of this work was based on ANVISA's RDC 166, 2017 and the Guide 10, version 1, 2017, guided the statistical treatments adopted. The selectivity study found that the presence of impurities or excess excipients did not interfere with product quantification. The proposed methods were linear with linear correlation coefficients (r) above 0.99. The precision and repeatability presented relative standard deviation values lower than specified (RSD < 5 %). The small controlled variations in the method suggested for the robustness test also did not affect the radiochemical purity of the product. In view of the results and in accordance with the criteria established by the National Health Surveillance Agency (ANVISA), the two chromatographic methods were validated in accordance with RDC 166, 2017, proving to be selective, precise, linear and robust. The validation of TLC and HPLC methods enables their application in the batch release routine of the new radiopharmaceutical at Radiopharmacy Center of IPEN

Como referenciar
SANTOS, JOEL M.; BALIEIRO, LUIZA M.; SANTOS, RODRIGO S.; MATSUDA, MARGARETH M.N.; ARAUJO, ELAINE B. Validation of chromatographic analytical methods, TLC and HPLC, to determine the radiochemical purity on the radiopharmaceutical [177Lu]-PSMA I&T. SSRN Electronic Journal, p. 1-9, 2024. DOI: 10.2139/ssrn.4920580. Disponível em: https://repositorio.ipen.br/handle/123456789/50070. Acesso em: 30 Jun 2026.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.

Agência de fomento

Coleções